Acute myeloblastic leukemia with maturation

MONDO:0020320

An acute myeloid leukemia (AML) characterized by blasts with evidence of maturation to more mature neutrophils. (WHO, 2001)

Also known as: AML M2, AML with maturation, FAB M2, M2 acute granulocytic leukaemia, M2 acute granulocytic leukemia, M2 acute myeloblastic leukaemia, M2 acute myeloblastic leukaemia with maturation, M2 acute myeloblastic leukemia

3104 clinical trials for this condition and its sub-types, 26 tagged with Acute myeloblastic leukemia with maturation itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Acute myeloid leukemia by FAB classification (59)

Including sub-types (3104) Tagged with Acute myeloblastic leukemia with maturation (26)

Trials to join now! 7 Not yet recruiting 4 Not yet finished but already full! 7 Completed 7 Terminated 1

Experimental immune cell therapy targets tough leukemia

Disease control Stopped early

This early-phase study tested an off-the-shelf natural killer (NK) cell therapy called SAR445419 in adults with acute myeloid leukemia that returned or didn't respond to treatment. Participants received chemotherapy followed by the NK cells to see if it was safe and could help co…

Phase 1 • Sponsor: Sanofi • Aim: Disease control

Last updated Jun 27, 2026 13:04 UTC

Acute myeloblastic leukemia with maturation

Where it sits in the disease tree

Experimental immune cell therapy targets tough leukemia